Fate Therapeutics, Inc. (FATE) Balance Sheet
As of 2026-06-30 (10-Q), Fate Therapeutics, Inc. (FATE) reported total assets of $260.1M and shareholders' equity of $153.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $32.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FATEFate Therapeutics, Inc.Follow FATE — free
—
Price chart with a free account
- Market cap
- 252.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 54.0 | 49.1 | 64.8 | 88.6 | 89.0 | 190.5 | 99.8 | 167.3 | 133.6 | 61.3 | 41.9 | 36.1 | 46.6 | 32.4 | |
| Short-term investments | — | — | — | 3.5 | — | — | — | — | 482.3 | 374.9 | 273.3 | 243.0 | 157.0 | 121.3 | |
| Receivables | — | — | — | — | — | 0.5 | — | 5.5 | 8.7 | 38.5 | 1.8 | 3.5 | 0.9 | 0.7 | |
| Current assets | 54.7 | 49.9 | 65.7 | 93.3 | 102.6 | 205.2 | 227.1 | 494.3 | 633.4 | 502.1 | 331.5 | 291.9 | 208.7 | 158.0 | |
| Total assets | 55.6 | 51.2 | 68.0 | 95.0 | 105.3 | 213.0 | 302.3 | 622.5 | 921.5 | 705.6 | 506.2 | 440.7 | 318.9 | 260.1 | |
| Current liabilities | 4.6 | 4.6 | 13.4 | 15.2 | 11.0 | 27.3 | 27.8 | 85.6 | 81.3 | 114.1 | 39.1 | 38.5 | 36.1 | 32.6 | |
| Long-term debt | 1.8 | 19.6 | 21.6 | 12.8 | 19.3 | 18.5 | — | — | — | — | — | — | — | — | |
| Short-term debt | 1.7 | 1.5 | 7.6 | 8.2 | — | 2.4 | — | — | — | — | — | — | — | — | |
| Shareholders' equity | 50.8 | 28.3 | 38.0 | 73.2 | 77.2 | 160.5 | 244.8 | 384.4 | 678.8 | 483.9 | 368.4 | 318.7 | 207.2 | 153.4 |
USD millions · SEC XBRL
Fate Therapeutics, Inc. — questions
- How much cash does Fate Therapeutics, Inc. have?
- $32.4M in cash and cash equivalents as of 2026-06-30.
- What are Fate Therapeutics, Inc.'s total assets?
- $260.1M as of 2026-06-30.
- What is Fate Therapeutics, Inc.'s shareholders' equity?
- $153.4M as of 2026-06-30.
Every figure on this page comes from Fate Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.